Price
Target price
€59.32
€59.32
0.640%
0.38
0.640%
€60.24
13:29 / Tradegate
WKN: A2ACMZ / Symbol: IONS / Name: Ionis Pharmaceuticals / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 0.640% compared to yesterday.
The stock is one of the favorites of our community with 40 Buy predictions and 2 Sell predictions.
With a target price of 60 € there is a slightly positive potential of 1.15% for Ionis Pharmaceuticals Inc. compared to the current price of 59.32 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 0.640% | 7.712% | 12.782% | 70.692% | 73.200% | 26.644% | 52.655% |
| Ironwood Pharmaceuticals | -0.800% | 5.932% | 28.866% | -67.784% | -70.238% | -87.981% | -84.848% |
| Novocure Ltd | -1.210% | 12.483% | 18.282% | -7.606% | -57.452% | -85.785% | -87.799% |
| Iovance Biotherapeutics Inc. | 0.500% | -1.196% | -11.575% | -80.254% | -72.734% | -79.987% | -92.125% |
Comments
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Bank of America Corporation from $81.00 to $83.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
